Announcements Trials
Browse Landscape

Phase

Phase 2 17Phase 1 6Phase 1/2 5Phase EARLY_PHASE1 2Phase 3 2

Status

Unknown 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2Other hematologic neoplasm 1

Conditions

Recurrence 7Multiple Myeloma 6Neoplasms 5Burkitt Lymphoma 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Ovarian Neoplasms 4Lymphoma, Mantle-Cell 4Lymphoma, Large B-Cell, Diffuse 4Lymphoma 4Lymphoma, Non-Hodgkin 3Leukemia, Myeloid, Acute 3Leukemia, Lymphocytic, Chronic, B-Cell 3Waldenstrom Macroglobulinemia 2Solid Tumor 2Small Cell Lung Carcinoma 2Sarcoma 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Pancreatic Neoplasms 2Neuroblastoma 2Neoplasms, Plasma Cell 2Neoplasm Metastasis 2Nasopharyngeal Carcinoma 2Melanoma 2Medulloblastoma 2Lymphoma, T-Cell, Peripheral 2Lymphoma, T-Cell 2Lymphoma, Follicular 2Lymphoma, B-Cell, Marginal Zone 2Leukemia, Large Granular Lymphocytic 2Intraocular Lymphoma 2

Interventions

fludarabine 2Cyclophosphamide 2pegylated granulocyte colony-stimulating factor, human 1pegfilgrastim 1pegaspargase 1dexamethasone acetate 1Tetrahydrouridine 1Surveys and Questionnaires 1Sugars 1Melphalan 1Loratadine 1Lenalidomide 1Decitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Lymphoma, T-Cell × Cyclophosphamide × Clear all
NCT06224049 2024-03-12

GI-hNeoT-01

BGI, China

Phase EARLY_PHASE1 Recruiting
6 enrolled
Lymphoid

Lymphoma, T-Cell, Epstein-Barr Virus Infections

NCT04264078 2021-06-28

Anti-CD7 U-CAR-T Cell Therapy for T/NK Cell Hematologic Malignancies

Xinqiao Hospital of Chongqing

Phase EARLY_PHASE1 Unknown
30 enrolled
LymphoidOther hematologic neoplasm

Leukemia, T-Cell, Lymphoma, T-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡